Ambu A/S (CPH:AMBU.B)
Denmark · Delayed Price · Currency is DKK 65.10
+0.90 (1.40%)
May 19, 2026, 11:50 AM CET
Ambu A/S Market Cap
Ambu A/S has a market cap or net worth of 17 billion as of May 19, 2026. Its market cap has decreased by -45.27% in one year.
Market Cap
17.00B
Enterprise Value
16.86B
Revenue
6.10B
Ranking
n/a
PE Ratio
35.86
Stock Price
65.10
Market Cap Chart
Since August 8, 1994, Ambu A/S's market cap has increased from 290.04M to 17.00B, an increase of 5,760.97%. That is a compound annual growth rate of 13.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 18, 2026 | 17.00B | -27.41% |
| Dec 30, 2025 | 23.42B | -15.47% |
| Dec 30, 2024 | 27.70B | -1.11% |
| Dec 29, 2023 | 28.01B | 23.89% |
| Dec 30, 2022 | 22.61B | -48.49% |
| Dec 30, 2021 | 43.90B | -32.73% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.33T |
| Genmab | 103.39B |
| Coloplast | 89.91B |
| ALK-Abelló | 56.01B |
| Demant | 49.73B |
| H. Lundbeck | 39.95B |
| Zealand Pharma | 21.94B |
| Bavarian Nordic | 14.40B |